Delivery Order SPE2DB22D9151-SPE2DB24FM8EV
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The delivery order was issued on December 5, 2023 against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to five million dollars through...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Xolair 150 mg/1.2 ml powder vials. The $15,474 delivery order has a completion date of December 29, 2023 and was awarded on December 7, 2023. DMS Pharmaceutical Group will deliver the pharmaceutical items to the Park Ridge, Illinois location of the Defense Logistics Agency Troop Support Medical. As a woman-owned small business, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency Troop Support Medical to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply needed pharmaceutical items and medical products to military treatment centers supported by the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand six hundred forty-two dollars and twenty cents ($4,642.20) by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to five million dollars through December 2025....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twelve thousand three hundred seventy-nine dollars and twenty cents ($12,379.20) by the Defense Logistics Agency to supply Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. No...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand six hundred five dollars and fifty cents ($11,605.50) by the Defense Logistics Agency. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to the Defense Logistics Agency with a potential value of up to five million dollars through December 2025. Under this order, DMS Pharmaceutical Group will deliver...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $77,370 under an indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group will deliver the pharmaceutical products to Park Ridge, Illinois by December 2023. DMS Pharmaceutical Group currently supplies various medical supplies and pharmaceuticals to support military treatment facilities...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty thousand nine hundred forty-eight dollars ($30,948) by the Defense Logistics Agency Troop Support Medical. This order is placed against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS Pharmaceutical Group will provide...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at four thousand six hundred forty-two dollars and twenty cents ($4,642.20) by the Defense Logistics Agency to supply Xolair 150 MG/ML syringes. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $6,189.60 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order....
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB24FM8EVDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-seven thousand eight hundred fifty-three dollars and twenty cents ($27,853.20) by the Defense Logistics Agency to supply Xolair 150 mg/1.2 ml powder vials. The delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. DMS Pharmaceutical Group will deliver the Xolair powder vials to support military treatment facilities operated by the Defense Logistics Agency. As a woman-owned small business and pharmaceutical wholesaler, DMS Pharmaceutical Group has extensive experience supplying prescription drugs and medical products to the Department of Defense through various prime vendor and delivery order contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.9k | 11/28/23 |